Healthcare & Assistive

A hardware-first assessment of commercial rehab exoskeletons, grading EksoNR, ReWalk, and Cyberdyne HAL by verified deployments and peer-reviewed outcomes. Includes India availability, landed cost estimates, and implementation constraints.

A measured assessment of elder-care companion and assistive robots, graded by actual shipping hardware, verified pilot deployments, and commercial availability, with explicit notes on India import pathways and landed cost estimates.

A factual assessment of commercial hospital autonomous mobile robots, grading claims by shipped hardware and verified deployments. Covers Aethon TUG logistics platforms, Diligent Robotics Moxi workflow support, navigation and safety standards, integration realities, and India availability with landed cost estimates.

An evidence-based assessment of the commercial surgical robotics landscape, grading da Vinci, Hugo SRS, and Versius by verified shipping hardware, pilot deployments, and India availability. Pricing, regulatory pathways, and soft-tissue engineering constraints are evaluated without concept hype.

A hardware-first assessment of the da Vinci, Hugo RAS, and Versius platforms in the soft-tissue surgical domain, including technical constraints, service economics, and India hospital deployment status.

A hardware-first assessment of commercial rehab exoskeletons, grading ReWalk, Ekso Bionics, and Cyberdyne HAL by shipped units, pilot deployments, and clinical evidence, with explicit notes on India availability and landed pricing.

A grounded analysis of shipping elder-care robots, assistive home companions, and therapeutic devices, graded by actual hardware deployments, pilot programs, and manufacturer announcements, with explicit India availability and landed cost estimates.

A grounded assessment of hospital autonomous mobile robots, focusing on Aethon TUG and Diligent Robotics Moxi. We evaluate shipping hardware, verified pilot deployments, clinical integration, and India availability, separating manufacturer claims from on-floor reality.

A grounded evaluation of the soft-tissue surgical robotics sector, graded by shipping hardware status, clinical pilot deployments, and regulatory milestones. Covers Intuitive da Vinci, Medtronic Hugo, and CMR Robotics Versius, with explicit notes on India availability, landed cost estimates, and independent verification pathways.

An evidence-first review of the rehab exoskeleton market, evaluating shipped hardware from ReWalk, Ekso Bionics, and Cyberdyne HAL, grading clinical efficacy by peer-reviewed data and regulatory clearances, and mapping landed costs and pilot deployments in India.

A grounded assessment of ElliQ, Paro, Lovot, and assistive home companions, graded by deployment status, technical specifications, and India market availability.

An evidence-based assessment of commercial hospital autonomous mobile robots, focusing on Aethon TUG and Diligent Moxi, their deployment history, technical specifications, safety certifications, and availability in the Indian market.

A grounded assessment of the current surgical robotics landscape, grading systems by verified shipping hardware and pilot deployments rather than announcements. Coverage includes da Vinci, Hugo, and Versius, with technical specifications, clinical realities, and India availability with landed cost estimates.

A grounded review of shipping rehab exoskeletons, clinical trial outcomes, regulatory clearances, and the practical realities of deployment and pricing in India.

A factual assessment of commercially available elder-care robots, including ElliQ, Paro, and Lovot, graded by deployment status, technical specifications, and India market availability.

A factual assessment of hospital autonomous mobile robots (AMRs), focusing on Aethon’s TUG delivery fleet and Diligent Robotics’ Moxi companion unit. We grade both systems by verified shipping hardware and pilot deployments, separate manufacturer claims from field performance, and outline India market availability with approximate landed cost estimates.

A hardware-first assessment of commercial rehab exoskeletons, evaluating ReWalk, Ekso Bionics, and Cyberdyne HAL against published clinical evidence, deployment constraints, and India availability with landed cost estimates.

A grounded assessment of shipping elder-care and assistive home companion robots, grading claims by hardware maturity, detailing real-world deployments, technical constraints, and India availability with landed cost estimates.

An objective assessment of autonomous mobile robots for hospital logistics, focusing on Aethon TUG and Moxi. Evaluates claims by shipping hardware first, then pilots, then announcements. Covers technical specifications, integration requirements, safety standards, India availability, and approximate landed costs.

A factual evaluation of the commercial surgical robotics market, graded by shipping hardware, pilot deployments, and regulatory status. Covers Intuitive’s da Vinci, Medtronic’s Hugo RAS, and CMR Surgical’s Versius, with clinical evidence, procurement considerations, and India market availability.

A hardware-first evaluation of the da Vinci, Hugo, and Versius surgical robot platforms, graded by shipping status, clinical integration, and landed cost realities in the Indian healthcare ecosystem.

A grounded assessment of the rehabilitation exoskeleton sector, evaluating ReWalk, Ekso Bionics, and Cyberdyne HAL against manufacturing maturity, clinical evidence, and import viability in India.

A grounded assessment of ElliQ, Paro, Lovot, and assistive home companions. Grading claims by shipping hardware first, pilot deployments second, and announcements last, with explicit notes on India availability, landed costs, and regulatory pathways.

An evidence-based overview of hospital autonomous mobile robots, focusing on shipping hardware, verified deployments, and practical integration of the Aethon TUG and Diligent Robotics Moxi in clinical logistics.